| |
| |
|
| Insider
Information: |
Leiden Jeffrey M |
| Relationship: |
Director |
| City: |
Abbott Park |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
229,179 |
|
|
Indirect Shares
|
8,575 |
|
|
| Direct
Value |
$28,525,926 |
|
|
|
Indirect Value
|
$243,722 |
|
|
| Total
Shares |
237,754 |
|
|
| Total
Value |
$28,769,648 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
President and COO, Dir... |
2006-03-24 |
209,401 |
2006-03-24 |
635 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Executive Chairman, Di... |
2024-02-20 |
13,778 |
2024-02-20 |
440 |
Premium* |
|
|
Quest Diagnostics Inc |
DGX |
Director |
2018-05-29 |
6,000 |
2014-12-01 |
0 |
Premium* |
|
|
Revolution Healthcare Acquisitio... |
REVH |
Director |
|
0 |
2021-03-17 |
7,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2024-02-20 |
4 |
D |
$420.58 |
$1,731,948 |
D/D |
(4,118) |
13,778 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2024-02-15 |
4 |
AS |
$419.16 |
$1,951,190 |
D/D |
(4,655) |
17,896 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2024-02-14 |
4 |
AS |
$419.04 |
$1,825,338 |
D/D |
(4,356) |
22,551 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2024-02-13 |
4 |
AS |
$419.13 |
$308,899 |
D/D |
(737) |
26,907 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2024-02-12 |
4 |
AS |
$419.22 |
$1,114,205 |
D/D |
(2,656) |
27,644 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2024-02-09 |
4 |
D |
$422.74 |
$3,402,212 |
D/D |
(8,048) |
30,300 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2024-02-08 |
4 |
D |
$421.73 |
$1,137,828 |
D/D |
(2,698) |
38,348 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,707 |
41,046 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,916 |
33,339 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2024-01-08 |
4 |
AS |
$419.07 |
$2,785,977 |
D/D |
(6,648) |
2,423 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2023-12-13 |
4 |
AS |
$399.41 |
$5,333,799 |
D/D |
(13,354) |
9,071 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2023-10-16 |
4 |
AS |
$374.00 |
$4,847,788 |
D/D |
(12,962) |
22,425 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2023-05-08 |
4 |
AS |
$349.00 |
$392,625 |
D/D |
(1,125) |
35,387 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2023-05-05 |
4 |
AS |
$349.38 |
$307,262 |
D/D |
(879) |
36,512 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2023-05-03 |
4 |
AS |
$349.22 |
$1,578,301 |
D/D |
(4,508) |
37,391 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2023-05-02 |
4 |
AS |
$349.48 |
$2,256,761 |
D/D |
(6,450) |
41,899 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2023-02-24 |
4 |
D |
$289.12 |
$3,969,618 |
D/D |
(13,730) |
48,349 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2023-02-13 |
4 |
D |
$298.26 |
$3,979,981 |
D/D |
(13,344) |
62,079 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2023-02-02 |
4 |
D |
$317.83 |
$1,137,196 |
D/D |
(3,578) |
75,423 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
76,578 |
79,001 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-07-25 |
4 |
OE |
$91.05 |
$5,494,139 |
D/D |
60,342 |
134,502 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-07-25 |
4 |
AS |
$279.44 |
$37,164,481 |
D/D |
(132,079) |
2,423 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-04-13 |
4 |
AS |
$289.04 |
$4,563,653 |
D/D |
(15,789) |
74,160 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-02-24 |
4 |
D |
$227.86 |
$2,766,448 |
D/D |
(12,141) |
89,949 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-02-17 |
4 |
D |
$232.51 |
$1,914,952 |
D/D |
(8,236) |
102,090 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
